Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray Kausik K. and Colhoun Helen M. and Szarek Michael and Baccara-Dinet Marie and Bhatt Deepak L. and Bittner Vera A. and Budaj Andrzej and Diaz Rene and Goodman Shaun G. and Hanotin Corinne and Harrington Robert A. and ODYSSEY OUTCOMES Committees and Investigators and Merkely Béla Péter and Ungi Imre and Katona András (kollab. közrem.): Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
LANCET DIABETES & ENDOCRINOLOGY, 7 (8). pp. 618-628. ISSN 2213-8587 (2019)

[thumbnail of Ray.pdf]
Preview
Text
Ray.pdf - Published Version

Download (1MB) | Preview
Item Type: Journal Article
Journal or Publication Title: LANCET DIABETES & ENDOCRINOLOGY
Date: 2019
Volume: 7
Number: 8
Page Range: pp. 618-628
ISSN: 2213-8587
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 31072777
DOI azonosító: https://doi.org/10.1016/S2213-8587(19)30158-5
Date Deposited: 2022. Feb. 04. 12:00
Last Modified: 2022. Feb. 04. 12:00
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/23453
Web of Science® Times Cited: 193 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year